GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026
GlaxoSmithKline PLC (GSK)
US:NYSE Investor Relations:
gsk.com/en-gb/investors
Company Research
Source: Business Wire
Sixteen organizations, awarded funding in 2025, are taking innovative, local approaches to boosting vaccination in communities across the USGrant recipients’ projects aim to modernize outreach campaigns, strengthen immunization systems and mobilize advocates to keep prevention top of mindIncreased funding is available for 2026, with applications now open for projects supporting vaccination for people of all ages PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced the 2025 recipients of its COiMMUNITY Initiative grant program, awarding a total of $2 million across 16 state, regional and national non-profits working to improve immunization rates across the US. Through COiMMUNITY, GSK invests in local efforts to improve vaccine education and uptake. Now in its third year, the Initiative will offer $3M in grants supporting projects that improve vaccine communication and delivery for people of all ages.Leonard Friedland, Vice President, Scientific Affairs and Public H
Show less
Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GSK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GSK alerts
High impacting GlaxoSmithKline PLC news events
Weekly update
A roundup of the hottest topics
GSK
News
- GSK (NYSE:GSK) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating on the stock.MarketBeat
- GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 MillionBusiness Wire
- GSK (NYSE:GSK) had its "hold" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here's Why [Yahoo! Finance]Yahoo! Finance
GSK
Sec Filings
- 2/5/26 - Form 6-K
- 2/4/26 - Form 6-K
- 2/2/26 - Form 6-K
- GSK's page on the SEC website